Published in Lab Business Week, June 11th, 2006
Included in the 2006 and 2005 results is a non cash compensation charge of $2.8 million and $0.4 million, respectively, for stock compensation expense pertaining to the company's issued and outstanding stock options and restricted stock units. Highlights of the company's consolidated balance sheets and statements of operations appear below. Detailed financial statements are included in the company's Form 10-Q for the quarter ended March 31, 2006...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week